White Paper
The Benefits of Real-time Nonclinical Safety Data Analysis
Monitoring ongoing nonclinical safety studies is essential for toxicologists aiming to adjust experimental designs and inform drug development decisions in real-time, yet accessing interim data from external contract research organizations often presents significant technical and cost hurdles. Certara software expertly bridges this gap by providing robust solutions that seamlessly unlock ongoing study data for sponsor visualization and analysis. By streamlining logistics and eliminating administrative barriers, the advanced platform empowers teams to evaluate toxicological findings immediately. Ultimately, Certara helps biopharmaceutical organizations enhance operational agility, optimize safety assessments, and successfully accelerate promising therapeutic candidates toward clinical evalu
